2,3-bis(4-hydroxyphenyl)-propionitrile and Demyelinating Diseases

2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Demyelinating Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, Y; Itoh, N; Spence, RD; Voskuhl, RR; Wisdom, AJ	1

Other Studies

1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Demyelinating Diseases

Article	Year
Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model. Journal of neuroscience research, 2013, Volume: 91, Issue:7 Topics: Animals; Axons; Demyelinating Diseases; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Freund's Adjuvant; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Neuroprotective Agents; Nitriles; Peptide Fragments; Propionates; Receptors, Estrogen; Severity of Illness Index	2013

Article

Year

Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model.

Journal of neuroscience research, 2013, Volume: 91, Issue:7

Topics: Animals; Axons; Demyelinating Diseases; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Freund's Adjuvant; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Neuroprotective Agents; Nitriles; Peptide Fragments; Propionates; Receptors, Estrogen; Severity of Illness Index

2013